ロード中...
Rotavirus Inner Capsid VP6 Acts as an Adjuvant in Formulations with Particulate Antigens Only
Novel adjuvants present a concern for adverse effects, generating a need for alternatives. Rotavirus inner capsid VP6 protein could be considered a potential candidate, due to its ability to self-assemble into highly immunogenic nanospheres and nanotubes. These nanostructures exhibit immunostimulato...
保存先:
| 出版年: | Vaccines (Basel) |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7565724/ https://ncbi.nlm.nih.gov/pubmed/32645976 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines8030365 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|